Prodelphindin Enhancement V-AG-A

Vaccinium corymbosum

Blueberry

Tier VProdelphindin Enhancement

Target Trait

3.6×

fold-change

Gallocatechin-based proanthocyanidin (prodelphindin) accumulation

Technical Specifications

SKU

SS-F-AST-433

Genomic Edits

GC Content

45.9%

Construct Length

4,356 bp

Promoter System

Tissue-specific 2A11

Expression System

Agrobacterium-mediated T-DNA

Host Strain

EHA105

Receptor Target

Polyphenol-astringency axis

IFI Score

360

Pathway Edits

F3-5H overexpression (flavonoid 3',5'-hydroxylase) for 3,5-dihydroxyl ring B substitution
F3H upregulation (flavanone 3-hydroxylase) for dihydromyricetin precursor supply
ANR co-activation (anthocyanidin reductase) for gallocatechin extension unit formation
LAR alternative allele for leucodelphinidin reductase activity toward gallocatechin
DFR-alt selection for leucodelphinidin substrate preference over leucocyanidin
T-DNA right-border optimized integration cassette

Key Interventions

F3-5H hydroxylation shift to 3',5'-dihydroxyl for prodelphindin unit biosynthesisGallocatechin precursor pool expansion via F3H/ANR co-activationDFR-alt allelic selection for prodelphindin branch preference over procyanidin pathwayAgrobacterium co-cultivation with acetosyringone induction

IFI Subscale Profile

IFI Profile

IFI-S

—

IFI-U

—

IFI-B

—

IFI-K

—

IFI-C

—

IFI-P

—

IFI-A

360

IFI-F

—

Use Case

Flagship high-prodelphindin blueberry extract production, premium functional ingredient formulation, pharmaceutical-grade prodelphindin standardization.

License

$9999 · Tier V License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Astringency · IFI-A All Modalities